Efferent Labs is actively seeking partners to assist in the advancement of our discoveries and technologies. Contact our partnering team at: email@example.com
43North is part of New York Governor’s Buffalo Billion initiative, driving new economic opportunities throughout Buffalo and Western New York. Efferent Labs (formerly Raland Therapeutics) was a winner in the inaugural 2014 competition. The competition operates through the support of New York Power Authority and Launch NY.
Z80 Labs is Buffalo’s first focused technology incubator, providing entrepreneurs the ability to build new and innovative tech companies. Startups invited to locate in Z80 Labs are given a wide array of services including office space, education programs, mentorship, amenities and infrastructure from local sponsors, as well as expert advice from renowned industry advisors.
Excell Partners, Inc.
Excell is a unique regional economic partnership established in cooperation with the University of Rochester and the State of New York to manage a state-supported fund which provides pre-seed and seed stage financing to high-tech start-up companies in the upstate New York region.
Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. The Company operates worldwide and has leading scientific experts, state-of-the-art technologies as well as key therapeutic expertise in the areas of neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology and infectious diseases. Evotec has long-term discovery alliances with partners including Bayer, CHDI, Sanofi, Genentech, Janssen Pharmaceuticals and UCB. In addition, the Company has existing development partnerships and product candidates both in clinical and pre-clinical development.
University of Rochester Medical Center
The University of Rochester Clinical and Translational Science Institute is one of 60 institutions nationwide with funding from the National Institutes of Health to lead the emerging field of clinical and translational research. The Institute is building the foundation to assist researchers at the University of Rochester and across Upstate New York to produce innovative technology and methods that more efficiently and more quickly advance treatments to patients and communities.
University at Buffalo CBLS
Home to over 250 biological, physical and computational scientists and research staff, the CBLS is a community resource that addresses industry’s bioinformatics and life sciences challenges, by developing breakthrough technologies, fostering entrepreneurship, facilitating workforce development and providing funding assistance to catapult your business to the next level.